HBV
HBV inhibitors are compounds designed to target and inhibit various stages of the Hepatitis B virus (HBV) lifecycle. These inhibitors can interfere with viral replication, assembly, or release, thereby reducing the viral load and helping to manage chronic HBV infections. Research into HBV inhibitors is crucial for developing effective antiviral therapies to prevent liver disease and cancer associated with HBV. At CymitQuimica, we offer a range of HBV inhibitors to support your research in virology, antiviral drug development, and infectious disease management.
Found 188 products of "HBV"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Fosclevudine alafenamide
CAS:Fosclevudine alafenamide (Compound EIDD-02173) is an antiviral agent that acts against HBV (EC50: 1.71 μM).Formula:C22H29FN3O9PColor and Shape:SolidMolecular weight:529.45HBV-IN-25
CAS:HBV-IN-25: oral HBV cccDNA reducer, anti-HBeAg, anti-HBV (IC50: 0.58/1.15 μM), soluble (>452 μg/mL), non-toxic.Formula:C18H14ClNO4Color and Shape:SolidMolecular weight:343.76PPT
CAS:PPT is a modulator of water-heme interactions of CYP2C9d and CYP125A1 in low-spin P450 complexes.Formula:C11H13N3Purity:98%Color and Shape:SolidMolecular weight:187.24DVR-23
CAS:DVR-23 is a potent inhibitor of HBV virus.Formula:C17H17F3N2O3SColor and Shape:SolidMolecular weight:386.39BAY39-5493
CAS:BAY39-5493 is a hepatitis B virus inhibitor and possess antiviral activity in vitro and in vivo.Formula:C17H15ClFN3O2SColor and Shape:SolidMolecular weight:379.84LP10
CAS:LP10 is a reverse type I inhibitor of Mycobacterium tuberculosis CYP125A1 and a Potent type II inhibitor of Trypanosoma cruzi CYP51.Formula:C24H28N4O2Color and Shape:SolidMolecular weight:404.5Isothiafludine
CAS:Isothiafludine is a HBV virus inhibitor that dramatically reduces the HBV DNA level in cells.Formula:C18H18FN3OS2Purity:99.71%Color and Shape:SolidMolecular weight:375.48Bersacapavir
CAS:Bersacapavir (JNJ-56136379) is an in vitro modulator of hepatitis B virus capsid assembly that inhibits HBV replication.Formula:C16H14F4N4O3SPurity:98.53%Color and Shape:SolidMolecular weight:418.37Pradefovir
CAS:Pradefovir (Remofovir) is a prodrug for chronic HBV, converting to PMEA in the liver with a Km of 60 μM and clearance of 359 ml/min.Formula:C17H19ClN5O4PPurity:97.50%Color and Shape:SolidMolecular weight:423.79Besifovir PM
Besifovir PM (LB80331 PM) is an analogue of Besifovir, a novel orally available acyclic nucleotide phosphonate for the treatment of chronic hepatitis B
Formula:C11H15N5OPurity:98.48% - 99.90%Color and Shape:SoildMolecular weight:233.27SHR5133
CAS:SHR5133 is a potent, orally active regulator of HBV capsid assembly that reduces HBV DNA (EC50: 26.6 nM).Formula:C19H18F4N6O2Color and Shape:SolidMolecular weight:438.38Emtricitabine triphosphate tetrasodium salt
CAS:Emtricitabine triphosphate tetrasodium salt is the tetrasodium salt form of the phosphorylated anabolite (-)-Emtricitabine triphosphate, an active nucleosideFormula:C8H9FN3Na4O12P3SPurity:98%Color and Shape:SolidMolecular weight:575.11Carbovir
CAS:Carbovir, an NRTI, induces mitochondrial toxicity in human liver cancer cells.Formula:C11H13N5O2Color and Shape:SolidMolecular weight:247.25ent-Entecavir
CAS:Ent-Entecavir, an enantiomeric impurity of Entecavir (an oral HBV drug), inhibits HBV replication as a reverse transcriptase inhibitor.Formula:C12H15N5O3Color and Shape:SolidMolecular weight:277.28HBV-IN-17
CAS:HBV-IN-17 (compound 8) is a potent regulator of HBV capsid assembly (EC50: 511 nM).Formula:C17H15F6N5O2Color and Shape:SolidMolecular weight:435.32HBF-0259
CAS:HBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells.Formula:C16H12Cl2FN5Purity:98.07% - 99.42%Color and Shape:SolidMolecular weight:364.2Ref: TM-T27527
2mg34.00€5mg49.00€1mL*10mM (DMSO)50.00€10mg71.00€25mg114.00€50mg172.00€100mg249.00€200mg349.00€Tobevibart
CAS:Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1].Purity:98%Color and Shape:LiquidHEC72702
CAS:HEC72702: New HBV capsid inhibitor, from GLS4. No CYP1A2, CYP3A4, CYP2B6 induction at 10μM.Formula:C24H26BrFN4O5SColor and Shape:SolidMolecular weight:581.45HBV-IN-41
CAS:HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1].Formula:C18H19ClFN5O3Purity:98%Color and Shape:SolidMolecular weight:407.83HBV-IN-13
CAS:HBV-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg).Formula:C22H25NO7Color and Shape:SolidMolecular weight:415.44
